PI
ANIK icon

PineBridge Investments’s Anika Therapeutics ANIK Stock Holding History

PineBridge Investments’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,348
Closed -$129K – 1050
2019
Q3 		$129K Buy
2,348
+895
+62% +$46K ﹤0.01% 907
2019
Q2 		$59K Sell
1,453
-22,149
-94% -$808K ﹤0.01% 882
2019
Q1 		$714K Buy
+23,602
New +$808K 0.01% 617
2018
Q2 		– Sell
-4,267
Closed -$212K – 1079
2018
Q1 		$212K Sell
4,267
-5,744
-57% -$325K 0.01% 882
2017
Q4 		$539K Buy
10,011
+8,192
+450% +$453K 0.01% 801
2017
Q3 		$105K Sell
1,819
-112
-6% -$5.86K ﹤0.01% 934
2017
Q2 		$95K Buy
1,931
+21
+1% +$967 ﹤0.01% 929
2017
Q1 		$83K Buy
1,910
+31
+2% +$1.48K ﹤0.01% 960
2016
Q4 		$92K Hold
1,879
– – ﹤0.01% 995
2016
Q3 		$90K Buy
1,879
+61
+3% +$3.01K ﹤0.01% 817
2016
Q2 		$98K Buy
1,818
+98
+6% +$4.62K 0.01% 768
2016
Q1 		$77K Sell
1,720
-244
-12% -$9.9K ﹤0.01% 801
2015
Q4 		$75K Buy
1,964
+74
+4% +$2.83K ﹤0.01% 848
2015
Q3 		$61K Buy
1,890
+181
+11% +$6.31K ﹤0.01% 889
2015
Q2 		$56K Sell
1,709
-2,188
-56% -$78K ﹤0.01% 920
2015
Q1 		$161K Buy
3,897
+618
+19% +$25K 0.01% 805
2014
Q4 		$133K Buy
3,279
+139
+4% +$5.43K 0.01% 844
2014
Q3 		$115K Buy
3,140
+1,279
+69% +$55.3K ﹤0.01% 819
2014
Q2 		$86K Sell
1,861
-895
-32% -$39.8K ﹤0.01% 836
2014
Q1 		$114K Sell
2,756
-276
-9% -$10.3K ﹤0.01% 915
2013
Q4 		$116K Buy
+3,032
New +$93.5K ﹤0.01% 928

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

PineBridge Investments's ANIK Position: Q4 2019 in Review

PineBridge Investments sold out of Anika Therapeutics (ANIK) in Q4 2019, closing a stake of 2,348 shares — an estimated $129K sold.

PineBridge Investments first reported a position in ANIK in Q4 2013 and held it in 21 quarters. The position peaked at $714K in Q1 2019. 191 funds tracked by Wall St. Rank hold ANIK as of Q4 2019.

  • PineBridge Investments reported no remaining Anika Therapeutics position as of Q4 2019 after selling out during the quarter.
  • PineBridge Investments sold 2,348 Anika Therapeutics shares in Q4 2019, an estimated $129K.
  • PineBridge Investments first reported a position in Anika Therapeutics in Q4 2013 and held it in 21 quarters.
  • PineBridge Investments's Anika Therapeutics position peaked at $714K in Q1 2019.
  • 191 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2019.

Based on PineBridge Investments's 13F filing for Q4 2019, filed 13 Feb 2020.